Clinical Trials Browser

Lubiprostone × Clear all

NCT07405736 2026-02-12

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT03720613 2025-02-12

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

34,532 enrolled

Opioid-Induced Constipation

NCT01324284 2013-04-05

Lubiprostone

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms